Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Company Overview - Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation in the biopharmaceutical industry, collaborating with various entities from academic institutions to global pharmaceutical companies [2] - The company has a portfolio that includes royalties on more than 35 commercial products, such as Vertex's Trikafta, GSK's Trelegy, and Roche's Evrysdi, as well as 17 development-stage product candidates [2] Upcoming Events - Royalty Pharma is scheduled to participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, at 2:00 p.m. ET, with the webcast accessible on their "Events" page [1]